Sign in or create an account to add this stock to your watchlist.
About Burcon NutraScience (TSE:BU)
Burcon NutraScience Corporation develops plant protein extraction and purification technology in the field of functional and renewable plant proteins. The company's patented processes utilize oilseed for the production of purified plant proteins that exhibit nutritional, functional, and nutraceutical profiles. Its products include CLARISOY, a soy protein that offers clarity and protein nutrition for low and neutral pH beverage systems; Peazazz, a pea protein, which is soluble with clean flavor characteristics; and Puratein, Supertein, and Nutratein that are canola protein isolates with functional and nutritional attributes. The company's products are targeted at protein ingredient market, and for health and wellness applications. Its patent portfolio consists of 216 issued patents in various countries. The company was formerly known as Burcon Capital Corp. and changed its name to Burcon NutraScience Corporation in October 1999. Burcon NutraScience Corporation is headquartered in Vancouver, Canada.
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
SymbolTSE:BU
CUSIPN/A
Phone+1-604-7330896
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-10,747.86%
Return on Equity-630.98%
Return on Assets-159.82%
Miscellaneous
EmployeesN/A
Outstanding Shares43,942,000
Burcon NutraScience (TSE:BU) Frequently Asked Questions
What is Burcon NutraScience's stock symbol?
Burcon NutraScience trades on the Toronto Stock Exchange (TSX) under the ticker symbol "BU."
When is Burcon NutraScience's next earnings date?
Who are some of Burcon NutraScience's key competitors?
Some companies that are related to Burcon NutraScience include 4D Pharma (DDDD), Helix Biopharma (HBP), Ergomed (ERGO), Cardiome Pharma (COM), OncoCyte (OCX), InMed Pharmaceuticals (IMLFF), Navidea Biopharmaceuticals (NAVB), Botanix Pharmaceuticals (BOT), IntelGenx Technologies (IGX), BELLUS Health (BLU), Medicenna Therapeutics (MDNA), Destiny Pharma (DEST), NovaBay Pharmaceuticals (NBY), Rexahn Pharmaceuticals (RNN) and Abzena (ABZA).
Who are Burcon NutraScience's key executives?
Burcon NutraScience's management team includes the folowing people:
- Dr. Allan Yap, Chairman & CEO (Age 62)
- Mr. Johann Franz Tergesen MBA, CPA, CA, Pres & COO (Age 55)
- Ms. Jade Cheng MBA, CPA, CA, CFO & Treasurer
- Dr. Martin Hans Schweizer Ph.D., VP of Technical Devel.
- Ms. Kam T. Law B.Comm., L.L.B., Sr. VP of Legal & Corp. Sec. (Age 49)
Has Burcon NutraScience been receiving favorable news coverage?
News articles about BU stock have been trending somewhat positive on Sunday, Accern Sentiment reports. Accern rates the sentiment of media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Burcon NutraScience earned a coverage optimism score of 0.13 on Accern's scale. They also assigned headlines about the company an impact score of 46.77 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near future.
How do I buy shares of Burcon NutraScience?
Shares of BU and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Burcon NutraScience's stock price today?
One share of BU stock can currently be purchased for approximately C$0.60.
How big of a company is Burcon NutraScience?
Burcon NutraScience has a market capitalization of C$22.70 million.
How can I contact Burcon NutraScience?
Burcon NutraScience's mailing address is 1946 Broadway W, VANCOUVER, BC V6J 1Z2, Canada. The company can be reached via phone at +1-604-7330896.
MarketBeat Community Rating for Burcon NutraScience (BU)
MarketBeat's community ratings are surveys of what our community members think about Burcon NutraScience and other stocks. Vote "Outperform" if you believe BU will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BU will underperform the S&P 500 over the long term. You may vote once every thirty days.
Burcon NutraScience (TSE:BU) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | N/A | N/A | N/A | N/A |
| Consensus Rating Score: | N/A | N/A | N/A | N/A |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | N/A | N/A | N/A | N/A |
| Price Target Upside: | N/A | N/A | N/A | N/A |
Burcon NutraScience (TSE:BU) Consensus Price Target History
Burcon NutraScience (TSE:BU) Analyst Ratings History
Show:
| Date | Brokerage | Action | Rating | Price Target | Details |
|---|
| 9/7/2016 | Paradigm Capital | Boost Price Target | Buy | C$7.00 ➝ C$7.50 |  |
(Data available from 5/27/2016 forward)
Burcon NutraScience (TSE:BU) Earnings History and Estimates Chart
Burcon NutraScience (TSE BU) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 6/20/2018 | | | | | | | | |
| 2/9/2018 | Q3 2018 | | C($0.04) | | C$0.01 million | View | N/A | |
| 11/10/2017 | Q2 2018 | | C($0.03) | | C$0.01 million | View | N/A | |
| 8/11/2017 | Q1 2018 | | C($0.04) | | C$0.02 million | View | N/A | |
| 6/21/2017 | Q4 2017 | | C($0.04) | | C$0.13 million | View | N/A | |
| 2/10/2017 | Q3 2017 | | C($0.04) | | C$0.03 million | View | N/A | |
| 11/14/2016 | Q2 2017 | | C($0.04) | | C$0.02 million | View | N/A | |
| 8/15/2016 | Q1 2017 | | C($0.04) | | C$0.03 million | View | N/A | |
| 6/27/2016 | Q4 2016 | | C($0.04) | | C$0.04 million | View | N/A | |
| 2/12/2016 | Q3 2016 | | C($0.05) | | C$0.02 million | View | N/A | |
| 11/16/2015 | Q2 2016 | | C($0.04) | | C$0.02 million | View | N/A | |
| 8/14/2015 | Q1 2016 | | C($0.05) | | C$0.03 million | View | N/A | |
| 6/23/2015 | Q4 2015 | | C($0.05) | | C$0.03 million | View | N/A | |
| 2/16/2015 | Q3 2015 | | C($0.05) | | C$0.03 million | View | N/A | |
| 11/13/2014 | Q2 2015 | | C($0.05) | | C$0.02 million | View | N/A | |
| 8/14/2014 | Q1 2015 | | C($0.04) | | C$0.03 million | View | N/A | |
| 6/23/2014 | Q4 2014 | | C($0.04) | | C$0.02 million | View | N/A | |
| 2/13/2014 | Q3 2014 | | C($0.05) | | C$0.02 million | View | N/A | |
| 11/13/2013 | Q2 2014 | | C($0.05) | | C$0.02 million | View | N/A | |
| 8/13/2013 | Q1 2014 | | C($0.05) | | C$0.02 million | View | N/A | |
| 6/25/2013 | Q4 2013 | | C($0.04) | | | View | N/A | |
| 2/14/2013 | Q3 2013 | | C($0.06) | | | View | N/A | |
| 8/13/2012 | Q1 2013 | | C($0.04) | | | View | N/A | |
| 6/25/2012 | Q4 2012 | | C($0.04) | | | View | N/A | |
| 2/14/2012 | Q3 2012 | | C($0.06) | | | View | N/A | |
| 11/14/2011 | Q2 2012 | | C($0.06) | | | View | N/A | |
| 8/31/2011 | Q1 2012 | | C($0.04) | | | View | N/A | |
| 6/22/2011 | Q4 2011 | | C($0.09) | | | View | N/A | |
| 2/11/2011 | Q3 2011 | | C($0.06) | | | View | N/A | |
| 6/28/2010 | Q4 2010 | | C($0.07) | | | View | N/A | |
| 5/26/2009 | Q4 2009 | | C($0.07) | | | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
Burcon NutraScience (TSE:BU) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Burcon NutraScience (TSE BU) Insider Trading and Institutional Ownership History
Burcon NutraScience (TSE BU) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 2/12/2018 | Dorothy Kam To Law | Insider | Sell | 32,863 | C$0.01 | C$328.63 | | |
| 2/9/2018 | Randy Willardsen | Insider | Sell | 382,008 | C$0.00 | C$0.00 | | |
| 2/7/2018 | Jade Cheng | Insider | Sell | 10,178 | C$0.01 | C$101.78 | | |
| 2/7/2018 | Johann Franz Tergesen | Director | Buy | 10,000 | C$0.01 | C$100.00 | | |
| 2/1/2018 | Johann Franz Tergesen | Director | Buy | 100,000 | C$0.01 | C$1,000.00 | | |
| 1/29/2018 | Johann Franz Tergesen | Director | Buy | 50,000 | C$0.02 | C$1,000.00 | | |
| 1/26/2018 | Johann Franz Tergesen | Director | Buy | 50,000 | C$0.02 | C$1,000.00 | | |
| 1/24/2018 | Dorothy Kam To Law | Insider | Sell | 185,000 | C$0.03 | C$5,550.00 | | |
| 1/24/2018 | Johann Franz Tergesen | Director | Buy | 200,000 | C$0.03 | C$6,000.00 | | |
| 1/22/2018 | Peter Henry Kappel | Director | Buy | 20,000 | C$0.57 | C$11,400.00 | | |
| 1/16/2018 | Randy Willardsen | Insider | Buy | 20,000 | C$0.51 | C$10,200.00 | | |
| 1/12/2018 | David Lorne John Tyrrell | Director | Buy | 49,100 | C$0.61 | C$29,951.00 | | |
| 8/28/2017 | Peter Henry Kappel | Director | Buy | 8,500 | C$0.69 | C$5,865.00 | | |
| 1/20/2017 | Johann Franz Tergesen | Director | Buy | 5,000 | C$2.38 | C$11,900.00 | | |
| 1/13/2017 | Johann Franz Tergesen | Director | Buy | 5,000 | C$2.57 | C$12,850.00 | | |
| 12/2/2016 | Peter Henry Kappel | Director | Buy | 10,000 | C$2.58 | C$25,800.00 | | |
| 4/29/2015 | Dorothy Kam To Law | Insider | Sell | 85,019 | C$0.02 | C$1,700.38 | | |
| 4/23/2015 | Martin Hans Schweizer | Insider | Sell | 1,277 | C$0.02 | C$25.54 | | |
| 4/21/2015 | Johann Franz Tergesen | Director | Buy | 27,500 | C$0.03 | C$687.50 | | |
| 4/17/2015 | Michael Anthony Kirwan | Insider | Sell | 109,000 | C$0.03 | C$3,706.00 | | |
(Data available from 1/1/2013 forward)
Burcon NutraScience (TSE BU) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Today’s Research Reports on Burcon Nutrascience, Northland Power, dynaCERT and GreenPower Motor
finance.yahoo.com - May 7 at 3:52 PM |
 | Burcon Nutrascience (BUR) Announces Receipt of Nasdaq Letter Regarding Deficiency in Listing Compliance - StreetInsider.com
www.streetinsider.com - February 28 at 4:07 PM |
 | Burcon Announces Details of Completed Rights Offering - GlobeNewswire (press release)
globenewswire.com - February 20 at 3:56 PM |
| Burcon Congratulates Protein Industries Canada - GlobeNewswire (press release)
globenewswire.com - February 20 at 3:56 PM |
| Burcon Announces Details of Completed Rights Offering
finance.yahoo.com - February 19 at 3:47 PM |
| Burcon NutraScience Announces Transfer of Listing to Nasdaq Capital Market
finance.yahoo.com - February 6 at 8:30 AM |
 | Insider Buying: Burcon NutraScience Corp (BU) Director Buys 20,000 Shares of Stock
www.americanbankingnews.com - January 25 at 9:44 PM |
| Amendment to Burcon’s Rights Offering Announcement
finance.yahoo.com - January 22 at 4:52 PM |
| Burcon NutraScience Corp (BU) Insider Randy Willardsen Purchases 20,000 Shares
www.americanbankingnews.com - January 19 at 5:12 PM |
| Burcon NutraScience Corp (BU) Director David Lorne John Tyrrell Purchases 49,100 Shares
www.americanbankingnews.com - January 19 at 4:46 PM |
| Burcon Announces Board Change and Confirms No Material Undisclosed Information
finance.yahoo.com - December 21 at 4:49 PM |
| Burcon NutraScience Announces Receipt of NASDAQ Letters Regarding Delisting and Deficiency in Compliance With Certain Listing Rules
finance.yahoo.com - December 21 at 4:49 PM |
| Burcon Announces Appointment of David Ju to Its Board of Directors
finance.yahoo.com - December 21 at 4:49 PM |
| Who Are The Largest Shareholders In Burcon Nutrascience Corporation (TSX:BU)?
finance.yahoo.com - November 16 at 12:14 PM |
| Burcon NutraScience Corp. :BU-CA: Earnings Analysis: Q2, 2018 By the Numbers : November 14, 2017
finance.yahoo.com - November 14 at 5:16 PM |
 | Global plant based protein market is expected to reach USD 10892.3 million by 2022 supported by a CAGR of 6.7 ... - PR Newswire (press release)
www.prnewswire.com - October 25 at 6:18 PM |
| Burcon Announces Results of Shareholder Meeting
finance.yahoo.com - September 8 at 10:14 PM |
| Today's Research Reports on DIRTT Environmental Solutions, EcoSynthetix, Burcon NutraScience and Titanium Corporation
finance.yahoo.com - September 6 at 4:50 PM |
 | DGAP-News: Burcon Nutrascience teilt Erhalt eines Schreibens der Nasdaq ... - FinanzNachrichten.de
www.finanznachrichten.de - August 29 at 2:53 AM |
| Burcon Nutrascience (BUR) Receives Nasdaq Letter Regarding Deficiency in Compliance With Certain Listing Rules
www.streetinsider.com - August 26 at 4:34 AM |
| Burcon NutraScience Corp. :BU-CA: Earnings Analysis: Q1, 2018 By the Numbers : August 15, 2017
finance.yahoo.com - August 15 at 5:36 PM |
| See what the IHS Markit Score report has to say about Burcon NutraScience Corp.
finance.yahoo.com - August 9 at 10:00 PM |
| Burcon NutraScience Corp. :BU-CA: Earnings Analysis: Q4, 2017 By the Numbers : August 4, 2017
finance.yahoo.com - August 4 at 5:05 PM |
| Burcon NutraScience Corp. :BU-CA: Earnings Analysis: 2017 By the Numbers : August 2, 2017
finance.yahoo.com - August 2 at 5:32 PM |
| Pro-Trader Daily: Featured Company News - Cellectis Announced the IPO of its Subsidiary Calyxt
www.finanznachrichten.de - July 12 at 5:26 PM |
 | Burcon NutraScience Announces Receipt of Nasdaq Letter ... - Nasdaq
www.nasdaq.com - June 15 at 5:54 PM |
| Burcon NutraScience Engages Stonegate Capital Partners to Lead Investor Communications and Outreach Program - GlobeNewswire (press release)
globenewswire.com - May 19 at 8:58 AM |
| ITC Corporation Limited Provides Update Regarding Securities of Burcon NutraScience Corporation - GlobeNewswire (press release)
globenewswire.com - January 27 at 10:09 PM |
 | ITC Corporation Limited Provides Update Regarding Securities of Burcon NutraScience Corporation
www.marketwatch.com - January 27 at 2:59 AM |
| Form SC 13G/A Burcon NutraScience Corp Filed by: ITC Corp Ltd
www.streetinsider.com - January 20 at 5:08 PM |
| Soy Protein Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024
www.prnewswire.com - January 4 at 5:01 PM |
Burcon NutraScience (TSE:BU) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Burcon NutraScience (TSE BU) Stock Chart for Sunday, May, 27, 2018
Loading chart…
